DOES ADJUVANT CHEMOTHERAPY BENEFIT PATIENTS WITH NODE-POSITIVE, HORMONE-RECEPTOR POSITIVE, AND HER2 NEGATIVE BREAST CANCER?

被引：0
|
作者：
Harano, K. [1 ]
Hashimoto, K. [1 ]
Shimizu, C. [1 ]
Hirata, T. [1 ]
Yonemori, K.
Tamura, K. [2 ]
Katsumata, N. [1 ]
Ando, M.
Fujiwara, Y. [1 ]
机构：
[1] Natl Canc Ctr, Breast & Med Oncol Div, Tokyo, Japan
[2] Natl Canc Ctr, Outpatient Treatment Ctr, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：90 / 91
页数：2
相关论文
共 50 条
  • [1] Adjuvant chemotherapy in hormone-receptor positive HER2-negative early breast cancer
    Lopez, M.
    Di Lauro, L.
    Viola, G.
    Foggi, P.
    Conti, F.
    Corsetti, S.
    Sergi, D.
    Botti, C.
    Di Filippo, F.
    Vici, P.
    [J]. CLINICA TERAPEUTICA, 2009, 160 (06): : 481 - 488
  • [2] Axillary Response to Neoadjuvant Therapy in Node-Positive, Estrogen Receptor Positive, HER2 Negative Breast Cancer Patients
    Friedman-Eldar, O.
    Ozmen, T.
    Reyes, F. Valle
    Goel, N.
    Tjendra, Y.
    Moller, M.
    Kesmodel, S. B.
    Franceschi, D.
    Avisar, E.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S68 - S68
  • [3] Real-World Outcomes of Adjuvant Chemotherapy for Node-Negative and Node-Positive HER2-Positive Breast Cancer
    Veitch, Zachary
    Khan, Omar F.
    Tilley, Derek
    Ribnikar, Domek
    Kostaras, Xanthoula
    King, Karen
    Tang, Patricia
    Lupichuk, Sasha
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (01): : 47 - 56
  • [4] Current Landscape of Targeted Therapies for Hormone-Receptor Positive, HER2 Negative Metastatic Breast Cancer
    Ballinger, Tarah J.
    Meier, Jason B.
    Jansen, Valerie M.
    [J]. FRONTIERS IN ONCOLOGY, 2018, 8
  • [5] HER2 and response to paclitaxel in node-positive breast cancer
    Nash, Irwin
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (02): : 198 - 198
  • [6] HER2 and response to paclitaxel in node-positive breast cancer
    Hayes, Daniel F.
    Thor, Ann D.
    Dressler, Lynn G.
    Weaver, Donald
    Edgerton, Susan
    Cowan, David
    Broadwater, Gloria
    Goldstein, Lori J.
    Martino, Silvana
    Ingle, James N.
    Henderson, I. Craig
    Norton, Larry
    Winer, Eric P.
    Hudis, Clifford A.
    Ellis, Matthew J.
    Berry, Donald A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (15): : 1496 - 1506
  • [7] Triple negative breast cancer compared to hormone receptor negative/HER2 positive breast cancer
    Irfan Cicin
    Hakan Karagol
    Ufuk Usta
    Atakan Sezer
    Sernaz Uzunoglu
    Rusen Alas-Cosar
    Tarkan Yetisyigit
    Kazim Uygun
    [J]. Medical Oncology, 2009, 26 : 335 - 343
  • [8] Triple negative breast cancer compared to hormone receptor negative/HER2 positive breast cancer
    Cicin, Irfan
    Karagol, Hakan
    Usta, Ufuk
    Sezer, Atakan
    Uzunoglu, Sernaz
    Alas-Cosar, Rusen
    Yetisyigit, Tarkan
    Uygun, Kazim
    [J]. MEDICAL ONCOLOGY, 2009, 26 (03) : 335 - 343
  • [9] PROGNOSTIC SIGNIFICANCE OF PgR EXPRESSION IN HORMONE-RECEPTOR POSITIVE, HER2-NEGATIVE, NODE-NEGATIVE BREAST CANCER
    Ono, Makiko
    Hitoshi, Tsuda
    Yoshida, Masayuki
    Shimizu, Chikako
    Kinoshita, Takayuki
    Tamura, Kenji
    [J]. ANNALS OF ONCOLOGY, 2014, 25
  • [10] Adjuvant chemotherapy for elderly HER2/neu positive breast cancer patients
    Miryusupova, G.
    Shayusupov, N.
    [J]. BREAST, 2015, 24 : S63 - S63
12345